Dying in hospital with high-grade glioma: symptom burden, end-of-life care quality, and a compressed transition to comfort-focused medication
This retrospective study of high-grade glioma patients reveals that terminal hospital admissions are characterized by severe symptom burdens, a high prevalence of impaired consciousness preventing self-reporting, and a compressed transition to comfort-focused medication, highlighting the urgent need for earlier palliative referrals and neurologically tailored anticipatory prescribing.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
When a person is dying of cancer, the path to the end of life often follows a pattern that doctors have learned to recognize and manage. In many cases, the body slowly weakens, pain becomes the main concern, and the patient can still speak to their family and doctors, helping to decide what kind of care they want. This understanding has shaped how hospitals and hospices prepare for the final days, creating guidelines that encourage patients to move away from aggressive treatments and toward comfort care while they are still at home. However, this familiar pattern breaks down completely for people with a specific type of brain tumor called a high-grade glioma. These tumors grow rapidly inside the skull, and as they do, they damage the very parts of the brain that allow a person to think, speak, and make decisions. The final weeks of life for these patients are not defined by a slow physical decline that can be easily talked about, but by a sudden loss of the ability to communicate and a rapid shift in consciousness. Because the patient often cannot say what they are feeling or what they want, the usual rules for planning end-of-life care become difficult to apply, leaving families and doctors to navigate a confusing and often rushed transition.
Researchers at a university hospital in Poland set out to understand exactly what happens during this critical, final hospital stay for people with these brain tumors. They looked back at the medical records of thirty-one adults who had been admitted to a palliative care unit between 2020 and 2025. These were not patients who had been slowly moving toward the end of life in a hospice or at home; almost all of them arrived at the hospital in a crisis, either through the emergency room or by being transferred from another ward. The team wanted to see what symptoms these patients had when they arrived, how their bodies were functioning, and how the medicines they received changed from the moment they walked in until they died or were discharged.
The picture that emerged was stark. By the time these patients reached the hospital, their bodies were already in a state of severe decline. More than four out of five patients were so weak that they could barely move or care for themselves. The symptoms they suffered were almost entirely related to their brain function rather than general body aches. The most common problems were weakness in the limbs, seizures, and a clouding of consciousness. In fact, nearly eight out of ten patients were confused, unable to speak clearly, or barely awake when they arrived. This meant that the standard way doctors check on patients—by asking them how they feel—was impossible for the vast majority of this group. They could not tell the medical team if they were in pain or if they were scared.
The study also tracked the medicines these patients were taking, revealing a dramatic shift that happened very quickly once they were admitted. Before coming to the hospital, most patients were taking drugs designed to fight the tumor's effects, such as steroids to reduce brain swelling and anti-seizure medications. But once they were in the hospital, the focus of care flipped. The use of steroids and anti-seizure drugs dropped significantly, while the use of painkillers and sedatives rose sharply. This change happened in a matter of days. The hospital stay became the place where the decision to stop fighting the disease and start focusing entirely on comfort was made, often without the patient or their family having had a chance to discuss it beforehand.
The speed of this final chapter was perhaps the most surprising finding. For the two-thirds of patients who died in the hospital, the time from admission to death was very short. The median time was just under a month, but for many, it was much faster. More than a third of those who died passed away within a week of arriving. In nearly all cases, death came quietly as the body's vital functions slowly stopped, but in only a small fraction of these moments were family members actually present at the bedside. The researchers noted that the patients' ability to make decisions or communicate with loved ones often vanished long before they died, meaning that the window for having important conversations closed while the patient was still alive but no longer able to participate.
The laboratory tests taken during these stays showed that the patients' blood chemistry remained relatively stable, with only mild signs of the body shutting down. This suggests that the usual blood tests used to predict how long a person with other types of cancer might live are not very helpful for people with these brain tumors. Instead, the most reliable signs of the end were simply the neurological ones: the loss of movement, the inability to speak, and the deepening confusion.
The authors of the study conclude that the current system is failing these patients because the transition to comfort care is happening too late. Instead of a gradual shift that begins at home or in a hospice, the change is compressed into a few frantic days inside an acute hospital. The study suggests that doctors should not wait for a crisis to refer these patients to palliative care. Instead, the moment a patient's ability to function drops to a certain level, the conversation about goals of care should begin. This includes preparing specific medicines for symptoms that are hard to treat in a brain tumor, such as seizures that cannot be taken by mouth, and ensuring that families are involved in decision-making while the patient can still understand and speak. The goal is to move the transition from the hospital to the community, allowing the final days to be spent with dignity and with the people who matter most, rather than in a rushed and isolated hospital room.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.